Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Half a century after former President Richard Nixon launched the War on Drugs, a Miami-area private research clinic has kicked off a federally approved clinical trial to test LSD as a possible treatment for generalized anxiety disorder.
/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...
MindMed (MNMD) announced early Thursday that it had begun its phase 2b trial for its Generalized Anxiety Disorder (GAD) drug MM-120. Shares of the psy
– Phase 2b dose-optimization trial in patients with General Anxiety Disorder underway with first patient dosing expected in Q3 2022 – – Advanced IND-enabling...
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) CEO Robert Barrow sold 21,275 shares of the company’s stock in a transaction dated Thursday, June 16th. The stock was sold at an average price of 0.70, for a total transaction of 14,892.50. Following the completion of the sale, the chief executive officer now owns 3,955,619 shares […]